DiaMedica Therapeutics Inc.
For the period ended May 20, 2026. Filed Apr 1, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 20, 2026 · Filed Apr 1, 2026
DMAC$9.36+3.5%Stored close · as of Nov 6, 2026
Contents
Composition
The Board of Directors has determined that each member of the Compensation Committee is an “independent director” under the Nasdaq Listing Rules, a “non-employee director” within the meaning of Rule 16b-3 under the Exchange Act and otherwise independent under the rules and regulations of the SEC.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.